User profiles for Tetsuhiro Harimoto

TETSUHIRO HARIMOTO

Harvard University
Verified email at g.harvard.edu
Cited by 759

[HTML][HTML] A programmable encapsulation system improves delivery of therapeutic bacteria in mice

T Harimoto, J Hahn, YY Chen, J Im, J Zhang… - Nature …, 2022 - nature.com
Living bacteria therapies have been proposed as an alternative approach to treating a
broad array of cancers. In this study, we developed a genetically encoded microbial …

Enhancing the tropism of bacteria via genetically programmed biosensors

T Chien, T Harimoto, B Kepecs, K Gray… - Nature biomedical …, 2022 - nature.com
Engineered bacteria for therapeutic applications would benefit from control mechanisms
that confine the growth of the bacteria within specific tissues or regions in the body. Here we …

Zinc in depression: a meta-analysis

…, G Mazereeuw, K Goldberger, T Harimoto… - Biological …, 2013 - Elsevier
Background Zinc is an essential micronutrient with diverse biological roles in cell growth,
apoptosis and metabolism, and in the regulation of endocrine, immune, and neuronal functions …

A rapid screening platform to coculture bacteria within tumor spheroids

T Harimoto, D Deb, T Danino - Nature protocols, 2022 - nature.com
The prevalence of tumor-colonizing bacteria along with advances in synthetic biology are
leading to a new generation of living microbial cancer therapies. Because many bacterial …

Bacterial therapies at the interface of synthetic biology and nanomedicine

J Hahn, S Ding, J Im, T Harimoto, KW Leong… - Nature Reviews …, 2024 - nature.com
Bacteria are emerging as living drugs to treat a broad range of disease indications. However,
the inherent advantages of these replicating and immunostimulatory therapies also carry …

Rapid screening of engineered microbial therapies in a 3D multicellular model

T Harimoto, ZS Singer, OS Velazquez… - Proceedings of the …, 2019 - National Acad Sciences
Synthetic biology is transforming therapeutic paradigms by engineering living cells and
microbes to intelligently sense and respond to diseases including inflammation, infections, …

Predictors of readmission to a psychiatry inpatient unit

J Moss, A Li, J Tobin, IS Weinstein, T Harimoto… - Comprehensive …, 2014 - Elsevier
Objective To determine predictors of time to readmission to a general psychiatry inpatient
unit. Method Data from the Minimum Data Set-Mental Health (MDS-MH), a standardized …

[HTML][HTML] Respiratory-related hospitalizations following prophylaxis in the Canadian registry for palivizumab (2005–2012) compared to other international registries

B Paes, I Mitchell, A Li, T Harimoto… - Journal of Immunology …, 2013 - hindawi.com
Respiratory syncytial virus (RSV) infection occurs commonly in infants aged ≤2 years, and
severe infection results in hospitalization with accompanying morbidity and mortality. …

Outcomes of infants receiving palivizumab prophylaxis for respiratory syncytial virus in Canada and Italy: an international, prospective cohort study

…, M Maule, E Girardi, T Harimoto… - The Pediatric …, 2017 - journals.lww.com
Background: Respiratory syncytial virus (RSV) infection frequently results in RSV-related
hospitalization (RSVH) in young infants. We examined the outcomes of palivizumab recipients …

Risk factors for progression of Alzheimer disease in a Canadian population: the Canadian Outcomes Study in Dementia (COSID)

N Herrmann, T Harimoto, R Balshaw… - The Canadian …, 2015 - journals.sagepub.com
Objective: To determine risk factors for clinically significant progression during 12 months in
patients with mild-to-moderate Alzheimer disease. Method: Community-dwelling patients …